Inventaire - your friends and communities are your best library

Minimal clinically important differences in COPD lung function

Published in: COPD: Journal of Chronic Obstructive Pulmonary Disease

Date of publication: March 1, 2005

Language: English

Bibliographic databases:

Cites articles 45

Date

Title

Authors

July 1, 1987

Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects
December 1, 1989

Measurement of health status. Ascertaining the minimal clinically important difference

,
March 1991

Acceptability and reproducibility criteria of the American Thoracic Society as observed in a sample of the general population
June 1, 1992

Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group
March 1993

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society
November 1, 1994

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study
September 1995

Standardization of Spirometry, 1994 Update. American Thoracic Society
September 1, 1999

Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life
August 1, 1999

Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial
February 1, 2000

Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study
April 1, 2000

Relation of FEV(1) to clinical outcomes during exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group
May 13, 2000

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
June 1, 2001

Salmeterol plus theophylline combination therapy in the treatment of COPD.
July 1, 2001

Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study
March 1, 2002

Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research
May 1, 2002

Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD.
July 1, 2002

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol
October 1, 2002

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease
February 1, 2002

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium
April 1, 2002

Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD.
June 1, 2002

The FEV1/FEV6 predicts lung function decline in adult smokers
April 1, 2002

Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation
December 1, 2002

Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review
April 1, 2002

Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease
November 1, 2003

Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis
September 1, 2003

The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.
May 1, 2003

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD
October 1, 2003

Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD)

,
January 1, 2003

Bronchodilation test in COPD: effect of inspiratory manoeuvre preceding forced expiration
November 6, 2003

Repeatability of spirometry in 18,000 adult patients,Repeatability of Spirometry in 18,000 Adult Patients
November 1, 2003

Spirometric Reference Values for the 6-s FVC Maneuver *
January 1, 2003

Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD

,

Article -

Welcome to inventaire

The library of your friends and communities

Learn more